Top Tweets for #Mmsm
βοΈMultiple Myeloma Key Study Highlight from ASCO 2026 with Dr. Vincent Rajkumar
@VincentRK discusses #MajesTEC-9 w/ @OncBrothers
#multiplemyeloma #mmsm #HemOnc #OncTwitter #MedTwitter #ASCO26 @ASCO @MayoClinic @RoswellPark @IMFmyeloma
π Full Video: https://t.co/0MBdirzSf0
@CharlesMilrod Thanks for the HT! I am skeptical that SQ or on-body really improves time burden for patients. #mmsm
EAA241 - Ph 2 RCT Dara-Bor-Dex vs Cy-Bor-Dex in the treatment of Newly Diagnosed Multiple Myeloma with Light Chain Cast Nephropathy (LCCN) [Study activated 8/11/25] @keruakous
https://t.co/1NgvVZ3fTA #NCT07085728 #mmsm @eaonc
![mtmdphd's tweet photo. EAA241 - Ph 2 RCT Dara-Bor-Dex vs Cy-Bor-Dex in the treatment of Newly Diagnosed Multiple Myeloma with Light Chain Cast Nephropathy (LCCN) [Study activated 8/11/25] @keruakous
https://t.co/1NgvVZ3fTA #NCT07085728 #mmsm @eaonc https://t.co/NES1F0oNQ8](https://pbs.twimg.com/media/HNBsgN0WcAA9poK.jpg)
#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= @myelomaMD https://t.co/qD26HMx3J8 #NCT04566328 #mmMRD #mmsm @eaonc @mweissmdphd @VincentRK @LynneWagnerPhD Wei Snyder Kostakoglu @mtmdphd
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie https://t.co/VtBMJUjI5X
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd

CIBMTR, 807 patients after ide-cel: 1-yr PFS 46.5%, OS 67.3%. Infection-related mortality 1.1% by day +100 - but 2+ infections in those 100 days tracked with worse OS. Bacterial early, viral after day +30. Surveillance matters. #mmsm #myeloma #MedTwitter #MedEd

MAIC in triple-class exposed RRMM (BCMA-naΓ―ve): linvoseltamab vs elranatamab β higher ORR (71.5% vs 61.0%) & β₯CR (50.5% vs 37.4%), both p<0.05. OS favored linvoseltamab (HR 0.67). Unanchored comparison β read with caution. https://t.co/ImqVj08fdT #MultipleMyeloma #mmsm
Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dex (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol https://t.co/hXxlFINejC #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm #IDonc
![mtmdphd's tweet photo. Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dex (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol https://t.co/hXxlFINejC #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm #IDonc https://t.co/oZ4I5mtgek](https://pbs.twimg.com/media/HM8ntuHWQAApFcP.jpg)
#EAonc EAA173 - Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM) - PI: @nsc_natalie https://t.co/VtBMJUjI5X
Activated: Apr 30, 2019 #mmsm @eaonc #NCT03937635 @VincentRK @mweissmdphd

#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= @myelomaMD https://t.co/qD26HMx3J8 #NCT04566328 #mmMRD #mmsm @eaonc @mweissmdphd @VincentRK @LynneWagnerPhD Wei Snyder Kostakoglu @mtmdphd
EAA241 - Ph 2 RCT Dara-Bor-Dex vs Cy-Bor-Dex in the treatment of Newly Diagnosed Multiple Myeloma with Light Chain Cast Nephropathy (LCCN) [Study activated 8/11/25] @keruakous
https://t.co/1NgvVZ3fTA #NCT07085728 #mmsm @eaonc
![mtmdphd's tweet photo. EAA241 - Ph 2 RCT Dara-Bor-Dex vs Cy-Bor-Dex in the treatment of Newly Diagnosed Multiple Myeloma with Light Chain Cast Nephropathy (LCCN) [Study activated 8/11/25] @keruakous
https://t.co/1NgvVZ3fTA #NCT07085728 #mmsm @eaonc https://t.co/Le2FoCnPOZ](https://pbs.twimg.com/media/HM8nh1KWwAAvZvP.jpg)
I am sadly missing all the action at this wonderful @Myeloma_Society Genomic meeting. I heard there was a debate today on FISH versus the Next Generation. My bet is on the new kid on the block to chew up the FISH. #mmsm @szusmani @NBahlis @RaabMarc @IrenemGhobrial @FrancescoMaura4 @DrGarethMorgan1 #mmsm

Lively discussion on functional high risk myeloma at the IMS Genomics Workshop 2026 in Warsaw, Poland
#mmsm
@MyMKaiser @BrunoPaiva_UNAV @szusmani @NBahlis @nickbolli @FrancescoMaura4 @IrenemGhobrial

Will doublet maintenance become a new SOC? If so what about Tec/Dara at first relapse? #mmsm
1/6
Does doublet maintenance after ASCT improve outcomes in multiple myeloma?
We studied 410 patients treated at @fredhutch using propensity score matching and time-dependent survival analysis. π§΅
@BMTjournal https://t.co/PDswJqMnT3
Last Seen Hashtags on Sotwe
ε€§ε±θε
¬
Seen from Malaysia
ζε½±
Seen from United States
omegle
Seen from United States
nbbremen
Seen from United States
hayamasayuri
Seen from Indonesia
konyabosna
Seen from Turkey
mugla
Seen from Turkey
facundogonzalez
Seen from Italy
ΰΈ£ΰΈ±ΰΈΰΈΰΈ²ΰΈΰΈΰΈ±ΰΈΰΈ₯ΰΈΈΰΈ
Seen from Thailand
Baitedboys
Seen from Spain
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.8M followers

Barack Obama 
@barackobama
119.2M followers

Donald J. Trump 
@realdonaldtrump
111.7M followers

Cristiano Ronaldo 
@cristiano
111.3M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
97.8M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.1M followers

KATY PERRY 
@katyperry
88.1M followers

Taylor Swift 
@taylorswift13
81.9M followers

Lady Gaga 
@ladygaga
73.4M followers

Virat Kohli 
@imvkohli
70.5M followers

Kim Kardashian 
@kimkardashian
70M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.1M followers

Neymar Jr 
@neymarjr
63.3M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.9M followers

Selena Gomez 
@selenagomez
61.1M followers

X 
@x
60.8M followers













![mtmdphd's tweet photo. .@SWOG S2213 Ph3 RCT Dara-VC Induction Followed by ASCT or Dara-VCD Consolidation & Daratumumab Maintenance in Pts w/ Newly Diagnosed AL Amyloidosis [Activated: 12/1/23] https://t.co/OizUfJCc2c #mmsm #bmtsm https://t.co/z4pKH86yBC](https://pbs.twimg.com/media/HNBsUHiXoAApbvd.jpg)







![mtmdphd's tweet photo. Lenalidomide + high-dose dexamethasone (RD) vs lenalidomide + low-dose dex (Rd) as initial therapy for newly diagnosed multiple myeloma: an open-label RCT [10/22/2009] @VincentRK et al. @TheLancetOncol https://t.co/hXxlFINejC #NCT00098475 #EAonc E4A03 #mmsm #caxtx #ctsm #IDonc https://t.co/oZ4I5mtgek](https://pbs.twimg.com/media/HM8nsgbWMAE351D.jpg)
![mtmdphd's tweet photo. .@SWOG S2213 Ph3 RCT Dara-VC Induction Followed by ASCT or Dara-VCD Consolidation & Daratumumab Maintenance in Pts w/ Newly Diagnosed AL Amyloidosis [Activated: 12/1/23] https://t.co/OizUfJCc2c #mmsm #bmtsm https://t.co/Aw51d4LWec](https://pbs.twimg.com/media/HM8ncCSXUAAoEZh.jpg)


